[1] ZHAO Xin, TIAN Long, Qiang Ⅺ. Study on marker recognition using kV CBCT[J]. China Medical Devices, 34, 41-44(2019).

[2] YAN Jiecheng, TIAN Long, HU Yimin. Comparing the calibration accuracy of two image guided methods in bladder cancer radiotherapy[J]. Beijing Biomedical Engineering, 40, 303-308(2021).

[3] Lei Y, Tian S, Tian Z et al. Accurate CBCT prostate segmentation aided by CBCT-based synthetic MRI[J]. Medical Physics, 46, E132-E132(2019).

[4] Fontana F, Piacentino F, Ierardi A M et al. Comparison between CBCT and fusion PET/CT-CBCT guidance for lung biopsies[J]. CardioVascular and Interventional Radiology, 44, 73-79(2021).

[5] TIAN Long, FAN Xuewu, XU Rui et al. Comparison on T2WI and T2*WI for radiotherapy planning of prostate cancer[J]. Chinese Journal of Interventional Imaging and Therapy, 19, 239-244(2022).

[6] Yang X, Fu Y, Lei Y et al. Unsupervised learning-based CBCT-CT deformable image registration for CBCT-guided abdominal radiotherapy[J]. International Journal of Radiation Oncology*Biology*Physics, 111, e535-e536(2021).

[7] TIAN Long, XI Qiang, ZHAO Xin et al. Comparison of cone beam computed tomography calibrations based on soft tissue grey value and implanted markers in image-guided radiotherapy for bladder cancer[J]. Chinese Journal of Medical Physics, 35, 31-35(2018).

[8] Brown K H, Ghita M, Schettino G et al. Evaluation of a novel liquid fiducial marker, BioXmark®, for small animal image-guided radiotherapy applications[J]. Cancers, 12, 1276(2020).

[9] Thomas R A, Rasmas E Y, Morten A. Formula of gel for guided radiotherapy[P/OL]. (. https://doc.taixueshu.com/patent/CN105407927B.html

[10] de Ridder M, Gerbrandy L C, de Reijke T M et al. BioXmark® liquid fiducial markers for image-guided radiotherapy in muscle invasive bladder cancer: a safety and performance trial[J]. British Journal of Radiology, 93, 20200241(2020).

[11] Machiels M, Voncken F E M, Jin P et al. A novel liquid fiducial marker in esophageal cancer image guided radiation therapy: technical feasibility and visibility on imaging[J]. Practical Radiation Oncology, 9, e506-e515(2019).

[12] Rydhög J S, Mortensen S R, Larsen K R et al. Liquid fiducial marker performance during radiotherapy of locally advanced non small cell lung cancer[J]. Radiotherapy and Oncology, 121, 64-69(2016).

[13] De Roover R, Crijns W, Poels K et al. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer[J]. Medical Physics, 45, 2205-2217(2018).

[14] Kim H Y, Choi Y H, Lee S J. Effect of sedation anesthesia with intravenous propofol on transrectal ultrasound-guided prostate biopsy outcomes[J]. Journal of Korean Medical Science, 37, e115(2022).

[15] Helrich S, Pate W, Garg N et al. Comparison of magnetic resonance imaging to ultrasound for prostate sizing[J]. The Canadian Journal of Urology, 28, 10889-10899(2021).

[16] Takeda S, Fujimoto T, Onda K. Traumatic cervical vertebral artery dissection: a case with cerebral infarct due to newly formed thrombus in the cerebral arteries[J]. Neuropathology, 40, 501-506(2020).

[17] Xu C Y, Sun W G, Fang L Y et al. The value of multimodal imaging in the diagnosis of primary cardiac angiosarcoma[J]. Echocardiography, 38, 1474-1477(2021).